Obesity News

High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.

Adults who take semaglutide may have increased risk for developing suicidal thoughts, according to results from a case-control study published in JAMA Network Open.

A low-fat vegan diet significantly reduced harmful inflammatory dietary compounds compared with a Mediterranean diet, according to findings from a randomized study.

A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.

Beginning in 2026, prices for 10 drugs will be reduced for Medicare Part D recipients, according to a CMS press release.

Medicine was an interesting thought as I was growing up with no medical people in my family.

Maternal obesity may be linked to increased risk for sudden unexpected infant death, results from aa cohort study in JAMA Pediatrics suggest.

The FDA granted breakthrough device designation to an endoscopic procedure that resurfaces the duodenum lining to help people maintain weight loss after discontinuing GLP-1 receptor agonist treatment, according to a press release.

Quality testing of three counterfeit semaglutide products found low purity and more measured semaglutide than what was on the label, according to a research letter published in JAMA Network Open.

Individuals with type 2 diabetes who received semaglutide had lower probability for medical care related to tobacco dependence compared with other antidiabetes medications, the results of a study in the Annals of Internal Medicine showed.